Items in AFP with MESH term: Aspirin

Pages: Previous 1 2 3 Next

Aspirin for the Primary Prevention of Cardiovascular Events - Putting Prevention into Practice


Are Anticoagulants Better than Antiplatelet Agents for Treatment of Acute Ischemic Stroke? - Cochrane for Clinicians


Antiplatelet Therapy and Anticoagulation in Patients with Hypertension - Cochrane for Clinicians


Choosing Between Warfarin (Coumadin) and Aspirin Therapy for Patients with Atrial Fibrillation - Point-of-Care Guides


Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: Recommendation Statement - U.S. Preventive Services Task Force


Patient-Controlled Analgesia for Postoperative Pain - Cochrane for Clinicians


Transient Ischemic Attacks: Part II. Treatment - Article

ABSTRACT: Risk factors for stroke should be evaluated in patients who have had a transient ischemic attack. Blood pressure, lipid levels, and diabetes mellitus should be controlled. When applicable, smoking cessation and weight loss also are important. Angiotensin-converting enzyme inhibitor therapy may help prevent stroke. Aspirin is the treatment of choice for stroke prevention in patients who do not require anticoagulation. Clopidogrel is an alternative therapy in patients who do not tolerate aspirin. Atrial fibrillation, a known cardioembolic source (confirmed thrombus), or a highly suspected cardioembolic source (e.g., recent large myocardial infarction, dilated cardiomyopathy, mechanical valve, rheumatic mitral valve stenosis) are indications for anticoagulation.


Updated Recommendations on Daily Aspirin Use in Patients with Diabetes - Practice Guidelines


Rash and Fever in a College Student - Photo Quiz


Adding ACE Inhibitors or ARBs to Standard Therapy for Stable Ischemic Heart Disease - Implementing AHRQ Effective Health Care Reviews


Pages: Previous 1 2 3 Next


Information From Industry